Dr.Ram Abhinav,MBBS, MD , DM (Tata Memorial Hospital), MRCP-SCE (UK), ECMO (European Certification in Medical Oncology).,
MD Radiation Oncology in MS Ramaiah Medical College, Bangalore- Gold Medalist. DM Medical Oncology, Tata Memorial hospital, Mumbai, Published various academic papers in high indexed journals. Was awarded Neil-Joseph fellowship for academic excellence. Editorial Board in American Journal of Medical Case Reports.
Dr.Ram Abhinav,
MBBS, MD , DM (Tata Memorial Hospital), MRCP-SCE (UK), ECMO (European Certification in Medical Oncology).,
Direct Dial : 4324188
Experience
Senior Registrar, Tata Memorial Hospital, Mumbai (2015-2018). Medical Oncologist, Tata Memorial Hospital(2018-2019). Consultant Medical Oncologist, KMCH (2019).
Special Areas of Interest
ImmunotherapyTargeted therapyBreast Cancer Lung cancerProstate Cancer Colo-rectal cancer.
Memberships
Indian Society of Medical and Paediatric Oncology (ISMPO). European Society for Medical Oncology (ESMO). Cooperative Trials Group for Neuro-Oncology (COGNO). Member of Association of Radiation Oncologists- India (AROI). Member of American Brachytherapy Society (ABS) .
Research
Kannan RA,. Feasibility of concurrent chemoradiation in patients treated for carcinoma esophagus: A single institutional study. Euroasian Journal of Hepato-Gastroenterology 2014;4(1):11-13 . Patil V, Chandrasekharan A, Vallathol D, Malhotra M, Kannan RA. Antiemetic prophylaxis with temozolomide: an audit from a tertiary care center. Neuro-Oncology Practice 2019. Kannan RA, Janaki MG, Ponni ATR, et al. Analysis of late radiation proctitis among patients treated for cervical cancer: A Comparative study between linear accelerator and cobalt teletherapy. Clinical Ovarian and Gynaecological cancer 2014; 6(1):46-49. Kannan RA, Janaki MG, Ponni TR, et al. Comparison of manual and inverse optimisation techniques in high dose rate intracavitary brachytherapy of cervical cancer: A dosimetric study 2015;RPOR; 20(5):365-369 . Harjani RR, Janaki MG, Krishnaswamy UM, Alva RC, Ponni A, Koushik K, Somashekar MK, Kannan RA, Murthy AS. Epworth Sleepiness Scale- a novel tool to assess somnolence syndrome post radiotherapy to brain. Int J Cancer Ther Oncol 2015; 3(1):03014. Ritika R. Harjani, Manur G. Janaki, Mohankumar Somashekhar, Arul Ponni, Ram C. Alva, Kirthi Koushik, Kannan RA, Arvind Sathyamurthy. Feasibility of Concurrent Chemoradiation in Cervical Cancer Patients From Rural Background. Clinical Ovarian and Other Gynaecologic Cancer, Vol. 7, No. 1/2, 29-32. Ramaswamy A, Joshi A, Noronha V, Patil VM, Kothari R, Sahu A, Kannan RA, et al. Patterns of Care and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma—Results From a Tertiary Cancer Center in India, Clinical Genitourinary Cancer,2016, Vol. 15, No. 3, e345-355. VM Patil, Kannan RA, R Tonse , S Epari , T Gupta , R Jalali. A case series of salvage CCNU in high-grade glioma who have previously received temozolomide from a tertiary care institute in Mumbai. Indian J Cancer 2016; 53:558-61. Kannan RA, Koushik K, Kilara N, Gangoli A. Nasopharyngeal synovial sarcoma: An oncological surprise. International Journal of Cancer Therapy and Oncology 2014; 2(4): 2-4. Kannan RA, Koushik K, Muniyappa U, et al. Malignant Peripheral Nerve sheath tumor of Buccal Mucosa: An oncological surprise. American Journal of Medical Case Reports 2014;2(10):222-224. Kannan RA, Nambiar V, Koushik K, Alva RC, Muniyappa U. Nasopharyngeal adenoid cystic carcinoma - case report and review of literature. J Case Rep Onc Ther 2015; 1(1):1119. Murthy AS, Manur JG, Ponni ATR, Koushik KAS, Alva RC, Somashekar MK, Kannan RA, Harjani RR. A case of endometrial carcinoma with age related hyperkyphosis treated with definitive radiotherapy. Int J Cancer Ther Oncol 2015; 3(1):03016. Patil V, Kannan RA et al. Reverse swing‐M, phase 1 study of repurposing mebendazole in recurrent high‐grade glioma. Cancer Medicine 2020. Kannan RA et al. Dose to swallowing structures and dysphagia in head and neck Intensity Modulated Radiation Therapy - A long term prospective analysis RPOR. Jan 2020.